TipRanks
Bolt Biotherapeutics (DE:6LP0)
FRANKFURT:6LP0
Germany Market
6LP0
Bolt Biotherapeutics
RESEARCH TOOLSreports

Bolt Biotherapeutics (6LP0) Income Statement

0 Followers

Bolt Biotherapeutics Income Statement

Last quarter (Q2 2026), Bolt Biotherapeutics's total revenue was $5.00K, a decrease of -99.72% from the same quarter last year. In Q2, Bolt Biotherapeutics's net income was $-7.72M. See Bolt Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.70M$ 7.69M$ 7.88M$ 5.73M$ 1.26M
Gross Profit
$ 6.20M$ 7.69M$ -53.67M$ -67.39M$ -74.39M
Operating Expenses
$ 40.84M$ 80.74M$ 22.53M$ 22.93M$ 18.39M
Depreciation and Amortization
$ 1.49M$ 1.78M$ 1.85M$ 1.67M$ 1.19M
EBITDA
$ -31.89M$ -66.45M$ -67.34M$ -86.43M$ -97.40M
Operating Income
$ -34.63M$ -73.05M$ -76.20M$ -90.32M$ -92.79M
Other Income/Expenses
$ 1.26M$ 9.93M$ 7.00M$ 2.22M$ -5.80M
Pretax Income
$ -33.38M$ -63.12M$ -69.20M$ -88.10M$ -98.59M
Net Income
$ -33.38M$ -63.12M$ -69.20M$ -88.10M$ -98.59M
Per Share Metrics
Basic EPS
$ -17.85$ -1.65$ -1.83$ -2.30$ -2.79
Diluted EPS
$ -17.85$ -1.65$ -1.83$ -2.30$ -2.79
Weighted Average Shares Outstanding
 1.87M 1.91M 1.89M 1.87M 1.87M
Weighted Average Shares Outstanding (Diluted)
 1.87M 1.91M 1.89M 1.87M 1.87M
Currency in USD

Bolt Biotherapeutics Earnings and Revenue History